Effects of buccal misoprostol compared with vaginal misoprostol on first-trimester abortions: a randomized clinical trial
Researcher Bulletin of Medical Sciences,
Vol. 26 No. 1 (2021),
30 October 2021
Objective: Misoprostol can be used by different routes in the medical management of abortion. This study aimed to compare the efficacy and safety of buccal and vaginal administration of misoprostol for the completion of first-trimester abortions.
Materials and Methods: This study was a randomized clinical trial in which women with first-trimester abortion referred to Imam Hossein Medical Center in 2018 were studied. Women were randomly divided into two groups of buccal or vaginal misoprostol treatment. From the time of drug administration to complete abortion, side effects, duration of drug use until tissue excretion, need for blood transfusion and need for surgical evacuation were recorded and compared in two groups.
Results: One-hundred women (each group, 50 patients) were evaluated in this study. There was a significant difference between the two groups regarding the duration of misoprostol use (p-value = 0.028), and it was longer in the buccal group. Besides, there was a significant difference between the two groups in terms of the dose required until the tissue discharge (p-value = 0.034). In the buccal group, patients received higher doses of misoprostol. The rate of fever had a significant difference between the two groups and was more frequent in the vaginal group (p-value=0.023).
Conclusion: Vaginal misoprostol can be more effective in treating first-trimester abortions compared to buccal misoprostol and may be associated with longer duration of use and lower required doses.
- Abortion; First-trimester; Misoprostol; Buccal;Vaginal
How to Cite
2. Allison JL, Sherwood RS, Schust DJ. Management of first trimester pregnancy loss can be safely moved into the office. Reviews in obstetrics & gynecology. 2011;4(1):5-14.
3. Sifakis S, Angelakis E, Vardaki E, Fragouli Y, Koumantakis E. High-dose misoprostol used in outpatient management of first trimester spontaneous abortion. Archives of gynecology and obstetrics. 2005;272(3):183-6.
4. The American College of Obstetricians and Gynecologists Practice Bulletin no. 150. Early pregnancy loss. Obstetrics and gynecology. 2015;125(5):1258-67.
5. Cubo AM, Soto ZM, Haro-Pérez A, Hernández Hernández ME, Doyague MJ, Sayagués JM. Medical versus surgical treatment of first trimester spontaneous abortion: A cost-minimization analysis. PLoS One. 2019;14(1):e0210449-e.
6. Rausch M, Lorch S, Chung K, Frederick M, Zhang J, Barnhart K. A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss. Fertility and sterility. 2012;97(2):355-60.
7. Petersen SG, Perkins AR, Gibbons KS, Bertolone JI, Mahomed K. The medical management of missed miscarriage: outcomes from a prospective, single-centre, Australian cohort. The Medical journal of Australia. 2013;199(5):341-6.
8. Petrou S, Trinder J, Brocklehurst P, Smith L. Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial. BJOG : an international journal of obstetrics and gynaecology. 2006;113(8):879-89.
9. Parsons SM, Walley RL, Crane JMG, Matthews K, Hutchens D. Oral misoprostol versus oxytocin in the management of the third stage of labour. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 2006;28(1):20-6.
10. Sinha D, Shrivastava S, Shrivastava S. A comparative study of oral, sublingual and vaginal route of misoprostol as cervical ripening agent before surgical method of termination of first-trimester pregnancy. 2017. 2017;6(4):4.
11. Alfirevic Z, Aflaifel N, Weeks A. Oral misoprostol for induction of labour. The Cochrane database of systematic reviews. 2014(6):Cd001338.
12. Khan RU, El-Refaey H, Sharma S, Sooranna D, Stafford M. Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstetrics and gynecology. 2004;103(5 Pt 1):866-70.
13. Bhattacharjee N, Saha SP, Ghoshroy SC, Bhowmik S, Barui G. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks. The Australian & New Zealand journal of obstetrics & gynaecology. 2008;48(2):165-71.
14. Practice bulletin no. 143: medical management of first-trimester abortion. Obstetrics and gynecology. 2014;123(3):676-92.
15. You JH, Chung TK. Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis. Human reproduction (Oxford, England). 2005;20(10):2873-8.
16. World Health Organization. Safe abortion: technical and policy guidance for health systems. Geneva: WHO; 2003. Available at: http://www.who.int/reproductivehealth/ publications safe_abortion/safe_abortion.pdf. Retrieved October 28, 2008. [Internet].
17. Middleton T, Schaff E, Fielding SL, Scahill M, Shannon C, Westheimer E, et al. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception. 2005;72(5):328-32.
18. Garg G, Takkar N, Sehgal A. Buccal versus vaginal misoprostol administration for the induction of first and second trimester abortions. J Obstet Gynaecol India. 2015;65(2):111-6.
19. Fjerstad M, Sivin I, Lichtenberg ES, Trussell J, Cleland K, Cullins V. Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days. Contraception. 2009;80(3):282-6.
20. Creinin MD, Harwood B, Guido RS, Fox MC, Zhang J. Endometrial thickness after misoprostol use for early pregnancy failure. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2004;86(1):22-6.
21. Reynolds A, Ayres-de-Campos D, Costa MA, Montenegro N. How should success be defined when attempting medical resolution of first-trimester missed abortion? European Journal of Obstetrics and Gynecology and Reproductive Biology. 2005;118(1):71-6.
22. Schreiber CA, Creinin MD, Harwood B, Murthy AS. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days. Contraception. 2005;71(6):447-50.
23. Ngo T, Park MH, Free C. Safety and effectiveness of termination services performed by doctors versus midlevel providers: A systematic review and analysis. International journal of women's health. 2013;5:9-17.
- Abstract Viewed: 58 times